Provisions in the new tax and spending bill passed by the Senate would go even further than the House bill in removing health ...

Waiting about 9 months or more to rechallenge patients with amivantamab can improve outcomes in patients with colorectal cancer, data suggest.

Breast cancer patients may have inferior recurrence-free survival after neoadjuvant chemotherapy if they are overweight or obese at diagnosis.

Cuts that would target states could translate into fewer health services, medical professionals, and even hospitals, especially in rural communities.